CA-NANOTEMPER-TECH
NanoTemper Technologies, creator of high-quality, easy-to-learn biophysical tools for drug discovery, launches a new way for biologics researchers to screen humanized antibody therapeutics with the release of their Human Fc Labeling Kit. Optimized for use with Spectral Shift technology, an in-solution affinity screening method, scientists looking for innovative ways to accelerate candidate selection will appreciate the ability to measure affinities earlier in their workflow in crude lysate or cell media.
“With the Human Fc Labeling Kit, we’re enhancing the application of Spectral Shift technology, a proven breakthrough method for screening small molecules, by adding the ability to do affinity screening for antibody developability,” says Werner Streicher, VP of Research & Development at NanoTemper Technologies. “This is only the first step towards addressing the growing need for non-immobilized interaction measurements in the biologics space.”
Spectral Shift technology, built into Monolith X and Dianthus products, is the leading methodology for delivering reliable, in-solution affinities, and a must-try for anyone in early developability screening phases. For more information about the Human Fc Labeling Kits and other groundbreaking solutions like Dianthus and Monolith X from NanoTemper Technologies, please visit nanotempertech.com.
About NanoTemper Technologies
At NanoTemper, our vision is to help create a world where every disease is treatable. For us, that starts by equipping scientists with reliable tools that bring them the clarity, confidence, and momentum they need to discover and develop future therapies, even difficult ones. That’s why we build our tools with high-quality materials that give scientists the clearest results, we make our tools easy-to-learn, and we support our customers with practical expertise throughout their journey. Because the path to a disease-free world requires courage, big thinking, and collaboration, we’ll continue to create innovative products that meet the needs of our customers as they face new and difficult challenges.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231009503184/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VeriSilicon Launches the Industry-Leading Automotive-Grade Intelligent Driving SoC Design Platform29.4.2025 02:00:00 CEST | Press release
Providing one-stop custom service from chip design and verification to automotive-grade certification VeriSilicon (688521.SH) recently announced that its automotive-grade high-performance intelligent driving system-on-chip (SoC) design platform has been verified and successfully implemented in customer projects. Leveraging VeriSilicon’s Silicon Platform as a Service (SiPaaS) business model, this platform provides robust technical support for high-performance computing applications such as autonomous driving and advanced driver assistance systems (ADAS). VeriSilicon’s chip design process has obtained ISO 26262 automotive functional safety management system certification, enabling the company to provide global customers with one-stop custom service for their automotive chips that meet functional safety requirements. Combined with its extensive portfolio of automotive-grade IPs and complete intelligent driving software platform, VeriSilicon offers end-to-end support from chip design and v
IFF Pharma Solutions to Showcase Portfolio at Excipient World 202528.4.2025 23:00:00 CEST | Press release
Sustainability Expert Will Share Key Insights on Industry-Leading Solutions for Improving Environmental Impact IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable innovations, controlled-release formulations, and nitrosamine risk mitigation solutions at booth 205 from May 13-14, Gaylord National Resort and Convention Center, National Harbor, Maryland, USA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428283122/en/ “At IFF Pharma Solutions, we believe sustainability is not just a responsibility but an opportunity to innovate and inspire,” said Dr. Anne Adden, global strategic marketing director for sustainability and dietary supplements. “We are committed to creating solutions that not only meet the needs of today but also pave the way for a healthier, more sustainable future. Our team of problem-solve
Winka Dubbeldam Appointed Director and CEO of SCI-Arc28.4.2025 20:50:00 CEST | Press release
The Southern California Institute of Architecture (SCI-Arc) is thrilled to share that Prof. Winka Dubbeldam has been appointed as the next Director and Chief Executive Officer of SCI-Arc. A globally recognized Dutch architect, educator, and leader in design innovation, Winka will officially assume the role on September 1, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428994100/en/ Winka Dubbeldam Winka brings more than three decades of experience to the forefront of architectural practice and education. She is a full Professor of Architecture and served as Chair at the University of Pennsylvania Stuart Weitzman School of Design for ten years (2013–2023). Previously she initiated and directed the Post-Professional Architecture program for ten years (2003–2013), providing international students with innovative design skills, cutting-edge theoretical and technological knowledge necessary for a productive and innovativ
NIQ announces global data collaboration with The Trade Desk to enhance audience targeting28.4.2025 19:37:00 CEST | Press release
The Trade Desk is the first global technology platform to integrate new-to-market audiences NIQ, a leading consumer intelligence company, today announced a strategic global collaboration with The Trade Desk, a global leader in advertising technology. The collaboration will integrate NIQ's consumer intelligence and global insights on shopping behaviors into The Trade Desk’s platform, supporting marketers to plan and activate ad campaigns more accurately. These new-to-market audiences, now available on The Trade Desk's media buying platform, will enable advertisers to reach their desired audiences in global markets, with effectiveness and precision. "Our collaboration with The Trade Desk represents a significant step forward in our mission to provide actionable insights across the advertising industry, at a global scale," said Joshua Pisano, Global Head of Product, Media at NIQ. "By integrating NIQ’s advanced audiences into The Trade Desk’s leading data marketplace, we are empowering adv
Actus Nutrition Acquires Protein Facility from Foremost Farms USA28.4.2025 19:30:00 CEST | Press release
Deal includes exclusive long-term whey protein supply agreement Actus Nutrition (“Actus”), a leading vertically-integrated nutritional ingredients manufacturer and portfolio company of Butterfly Equity (“Butterfly”), today finalized an agreement to purchase a 99,000 sq. ft. processing facility from Foremost Farms USA (“Foremost Farms”). The facility, located in Sparta, WI, currently manufactures whey protein products, which Actus will continue producing at the location. As part of the deal, Actus and Foremost Farms will begin a long-term exclusive, network wide whey protein partnership supporting growth for both organizations. Actus plans to invest significant capital into the facility to increase capacity and expand its capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428226854/en/ Sparta, WI Facility “We’ll be able to hit the ground running because we can plug the Sparta facility into our existing manufactur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom